It followed, submitted the Commission, that Mr Narain contravened s 180(1) of the Act . DID MR NARAIN ENGAGE IN CONDUCT "IN RELATION TO" A FINANCIAL PRODUCT OR A FINANCIAL SERVICE? 30 The second statement contained in the 27 September letter of which the Commission made complaint was the statement that:  "Citrofresh provides a non-hazardous, non-toxic and effective solution that deal [sic] with emergency disease control and prevention for HIV, human influenza A virus, SARS virus and human rhinovirus". CIL sent it to the Stock Exchange through the medium of its company secretary. The announcement was attached.